GT Biopharma Inc Cash Flow Quality Index
GT Biopharma Inc cash flow quality index. GT Biopharma Inc (GTBP) has a Cash Flow Quality Index of -0.69x as of June 2016. Operating cash flow of $-1.06 Million is below net income of $1.54 Million, suggesting accrual-heavy earnings not yet converted to cash. See GT Biopharma Inc (GTBP) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of GT Biopharma Inc (1987–2016)
Cash flow quality index of GT Biopharma Inc from 1987 to 2016. Historical Cash Flow Quality Index for GT Biopharma Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore GT Biopharma Inc (GTBP) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
GT Biopharma Inc Cash Flow Quality Index by Year (1987–2016)
GT Biopharma Inc cash flow quality index by year from 1987 to 2016. Year-by-year earnings quality comparison for GT Biopharma Inc. For the full cash flow conversion analysis, see GTBP cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | -0.09x | $-1.93 Million | $21.03 Million | ▲ +90.5% |
| 2007 | -0.96x | $-270.00K | $280.00K | ▼ -196.4% |
| 1990 | 1.00x | $900.00K | $900.00K | ▲ +0.0% |
| 1989 | 1.00x | $700.00K | $700.00K | ▲ +0.0% |
| 1988 | 1.00x | $100.00K | $100.00K | ▲ +500.0% |
| 1987 | 0.17x | $50.00K | $300.00K | — |